Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
Date:9/29/2009

DETROIT, Sept. 29 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced today that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug manufacturing operations. The decree provides a series of measures that, when satisfied, will permit Caraco to resume manufacturing and distributing those products that are manufactured in its Detroit area facilities. The Company is working expeditiously to satisfy the requirements of the decree and has already retained independent cGMP experts for review of the Company's operations and to facilitate a successful result.

Under terms of the consent decree, Caraco's cessation of manufacturing operations will continue until it receives written notification from independent experts and the FDA that it is in compliance with the decree and regulations and can resume operations. Nothing in the decree prohibits Caraco from distributing FDA approved drug products that are manufactured by third parties.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limitation, the words "believe" or "expect" and similar expressions are intended to identify forward-looking statements. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties are contained in the Corporation's fili
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 Amerivet Solutions, LLC ( AMERIVET ... of government from Federal to Municipal, is pleased ... to include complex metal design and fabrication manufacturing. ... complex aluminum parts for the Defense Logistics Agency ... to service government contracts," states Richard Bergen ...
(Date:6/19/2013)... 19, 2013 DST Health Solutions, LLC (DSTHS), ... health plans, integrated delivery systems, and health care providers, ... Management Service (MDMS) has jumped significantly. ... the pricing of medical prescription drug claims, MDMS ... their medical drug claims processes. As specialty drug demand ...
(Date:6/19/2013)... June 19, 2013 /PRNewswire-iReach/ -- Today leading web researchers ... data ranking Pharmaceutical web sites for usability, engagement, and ... Experience Cloud platform, which compares how people experience sites ... web. The top three performers are easier ... overall. The bottom performers have usability problems, lack aspects ...
Breaking Medicine Technology:Amerivet Solutions Expands to Manufacture Complex Metal Designs 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2
... Fourth Annual Medical Product Outsourcing (MPO) Symposium kicks off ... strategist and entrepreneur Julia S. Rasor, founder of the ... device manufacturing efficiency by providing real-world examples of rudimentary ... flounder as different functional groups do their best to ...
... General Dynamics Information Technology, a business unit of ... awarded a contract to support the U.S. Army Medical ... medical facilities and transition to newly constructed facilities. The ... awarded by the U.S. Army Corps of Engineers, has ...
Cached Medicine Technology:MPO Symposium Keynote to Address Organizational Strategies for Medical Device Manufacturers 2General Dynamics Awarded Contract to Outfit and Transition U.S. Army Medical Facilities 2General Dynamics Awarded Contract to Outfit and Transition U.S. Army Medical Facilities 3
(Date:6/19/2013)... Citi Bike has come to New York City in a big ... for sure how many patients will choose to take advantage of ... In fact, he’s happy about anything that might help his ... convenient for them to visit his office at 133 East 58th ... at Back and Body Medical and an experienced NYC chiropractor ...
(Date:6/19/2013)... 2013 The Journal of Parasitology – ... computer software, it creates questions of ethics. For scientific ... an already published case shows, scientific publications need clear ... The Journal of Parasitology features a commentary ... 2004 article published in the Journal of the New ...
(Date:6/19/2013)... LOS ANGELES (June 19, 2013) In what is ... with the most common form of hereditary dystonia ... experts in deep brain stimulation report good success ... director of the Movement Disorders Program at Cedars-Sinai Medical ... chief of the Division of Neurosurgery at Beth Israel ...
(Date:6/19/2013)... understanding of the genetic process that can lead to ... lesions for some women, and also raises a warning ... cases suggesting they could actually trigger the cancer ... a clearer picture of the chromosomal and genetic changes ... to chronic infection and, in less than 1 percent ...
(Date:6/19/2013)... For those familiar ... name of the 10/90 gap: only 10 per cent of ... 90 per cent of the global disease burden. It was ... initiative (DNDi) came into being in 2003. Coinciding with its ... Foundation Frontiers of Knowledge Award in the Development Cooperation category. ...
Breaking Medicine News(10 mins):Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:Genetics of cervical cancer raise concern about antiviral therapy in some cases 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 3Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 4Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 5
... by progressive memory loss, decline in language skills and ... ageing population.// ,A recent paper in the ... in drug discovery. Hong-Yu Zhang, the author of the ... strategy in drug discovery is limited, which has stimulated ...
... responds to a diverse range of insults, such as ... wide range of cell types of the immune system, ... The inflammatory response, although essential for fighting infection, may ... anti-inflammatory mediators, cytokines and lipid mediators being the key ...
... Thompson and colleagues from University of Rochester Medical ... patients treated with corticosteroids that Corticosteroids is the ... mononucleosis, including severe airway compromise mononucleosis. The results ... of Otolaryngology – Head and Neck Surgery, JAMA ...
... of adults, rates of some pain conditions - particularly ... ranging from 20-50% of the teenage population.// ... are more prevalent in adult women than in men. ... associated with increased risk of migraine. Use of hormone ...
... for the development of kidney disease and is the ... However, whether pre-diabetes is associated with the development of ... declines in kidney function are present early on among ... to prevent the progression of kidney disease. Recently, researchers, ...
... have discovered that a deceptively simple sugar is in ... ,The discovery reveals that, when disturbed, this process ... to properly control the steps and timing of cell ... as O-GlcNAc (pronounced oh-GLUCK-nack), is used inside cells to ...
Cached Medicine News:Health News:The ideal composition of intravenous lipid emulsion 2Health News:Pubertal development may predispose women to pain and other symptoms 2Health News:Development of kidney disease in adults with pre-diabetes 2Health News:Sugar Helps Control Cell Division 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: